1,763
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system

Pages 326-345 | Received 15 Dec 2020, Accepted 02 Jul 2021, Published online: 22 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pengkui Xia, Tao Hou, Hong Jin, Yaqi Meng, Jing Li, Fuchao Zhan, Fang Geng & Bin Li. (2023) A critical review on inflammatory bowel diseases risk factors, dietary nutrients regulation and protective pathways based on gut microbiota during recent 5 years. Critical Reviews in Food Science and Nutrition 0:0, pages 1-17.
Read now
Himanshu Kumar. (2022) How metabolism and metabolites shape immunity during disease. International Reviews of Immunology 41:3, pages 297-298.
Read now

Articles from other publishers (13)

Moein Ala, Mohammad Reza Fallahpour Khoshdel, Razieh Mohammad Jafari, Mehrdokht Sadrkhanloo, Sepideh Goudarzi, Meisam Asl Soleimani & Ahmad Reza Dehpour. (2023) Low-dose sumatriptan improves the outcome of acute mesenteric ischemia in rats via downregulating kynurenine. Pharmacological Reports 75:3, pages 623-633.
Crossref
Chang Liu, Changwu Sun & Yuliang Cheng. (2022) β‐Glucan alleviates mice with ulcerative colitis through interactions between gut microbes and amino acids metabolism. Journal of the Science of Food and Agriculture 103:8, pages 4006-4016.
Crossref
Ting Liu, Zunxi Ning, Pengyu Liu & Huiyuan Gao. (2023) Cassane diterpenoid ameliorates dextran sulfate sodium-induced experimental colitis by regulating gut microbiota and suppressing tryptophan metabolism. Frontiers in Immunology 13.
Crossref
Elisa Proietti, Renske W.M. Pauwels, Annemarie C. de Vries, Elena Orecchini, Claudia Volpi, Ciriana Orabona, Maikel P. Peppelenbosch, Gwenny M. Fuhler & Giada Mondanelli. (2023) Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice. International Journal of Tryptophan Research 16, pages 117864692311531.
Crossref
Yanmei Chen, Jiahui Zhang, Yueying Yang, Ke Xiang, Hua Li, Dejuan Sun & Lixia Chen. (2022) Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression. Journal of Cellular Physiology 237:12, pages 4339-4355.
Crossref
Maurizio Ragni, Claudia Fornelli, Enzo Nisoli & Fabio Penna. (2022) Amino Acids in Cancer and Cachexia: An Integrated View. Cancers 14:22, pages 5691.
Crossref
Bat-Erdene Jugder, Juliana H. Batista, Jacob A. Gibson, Paul M. Cunningham, John M. Asara & Paula I. Watnick. (2022) Vibrio cholerae high cell density quorum sensing activates the host intestinal innate immune response. Cell Reports 40:12, pages 111368.
Crossref
Li-Jeng Chen, Tsai-Ching Hsu, Hsiang-Lin Chan, Chiao-Fan Lin, Jing-Yu Huang, Robert Stewart, Bor-Show Tzang & Vincent Chin-Hung Chen. (2022) Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy. International Journal of Molecular Sciences 23:16, pages 9247.
Crossref
Maohua Chen, Wei Lin, Nan Li, Qian Wang, Shaomi Zhu, Anqi Zeng & Linjiang Song. (2022) Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota. Frontiers in Microbiology 13.
Crossref
Xiaomin Su, Yunhuan Gao & Rongcun Yang. (2022) Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis. Cells 11:15, pages 2296.
Crossref
Ran Li, Xuanyang Wang, Yuntao Zhang, Xiaoqing Xu, Lulu Wang, Chunbo Wei, Lin Liu, Ziqi Wang & Ying Li. (2022) Analysis of Tryptophan and Its Main Metabolite Kynurenine and the Risk of Multiple Cancers Based on the Bidirectional Mendelian Randomization Analysis. Frontiers in Oncology 12.
Crossref
Jing Li, Ai-hua Zhang, Fang-fang Wu & Xi-jun Wang. (2022) Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Frontiers in Oncology 12.
Crossref
Artur Wnorowski, Sylwia Wnorowska, Jacek Kurzepa & Jolanta Parada-Turska. (2021) Alterations in Kynurenine and NAD+ Salvage Pathways during the Successful Treatment of Inflammatory Bowel Disease Suggest HCAR3 and NNMT as Potential Drug Targets. International Journal of Molecular Sciences 22:24, pages 13497.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.